title: Ligand/kappa-opioid receptor interactions: insights from the X-ray crystal structure.
abstract: During the past five years, the three-dimensional structures of 14 different G-protein coupled receptors (GPCRs) have been resolved by X-ray crystallography. The most recently published structures, those of the opioid receptors (ORs), are remarkably important in pain modulation, drug addiction, and mood disorders. These structures, confirmed previously proposed key interactions conferring potency and antagonistic properties, including the well-known interaction with Asp138, conserved in all aminergic GPCRs. In addition, crystallization of the opioid receptors highlighted the potential function of the ECL2 and ICL2 loops. We have previously reported a set of potent and selective kappa opioid receptor peptide agonists, of which ff(D-nle)r-NH₂ is among the most potent and selective ones. These peptides were identified from the deconvolution of a 6,250,000 tetrapeptide combinatorial library. A derivative of this set is currently the subject of a phase 2 clinical trial in the United States. In this work, we describe comparative molecular modeling studies of kappa-OR peptide agonists with the co-crystallized antagonist, JDTic, and also report structure-activity relationships of 23 tetrapeptides. The overall binding and contact interactions are sound and interactions known to favor selectivity and potency were observed. Additional modeling studies will reveal conformational changes that the kappa-OR undergoes upon binding to these peptide agonists.
authors.affiliation: Instituto de Química, UNAM, Av. Universidad 3000, México DF, Mexico. sasu_mx@yahoo.com
authors.forename: Karina
authors.initials: K
authors.lastname: Martinez-Mayorga
authors.forename: Kendall G
authors.initials: KG
authors.lastname: Byler
authors.forename: Austin B
authors.initials: AB
authors.lastname: Yongye
authors.forename: Marc A
authors.initials: MA
authors.lastname: Giulianotti
authors.forename: Colette T
authors.initials: CT
authors.lastname: Dooley
authors.forename: Richard A
authors.initials: RA
authors.lastname: Houghten
mesh_terms: D001665:Binding Sites; D018360:Crystallography, X-Ray; D008024:Ligands; D008958:Models, Molecular; D010456:Peptides, Cyclic / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D010880:Piperidines / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D011487:Protein Conformation; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D013329:Structure-Activity Relationship; D044005:Tetrahydroisoquinolines / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
chemical_list: C433814:7-hydroxy-N-(1-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide; D008024:Ligands; D010456:Peptides, Cyclic; D010880:Piperidines; D017473:Receptors, Opioid, kappa; D044005:Tetrahydroisoquinolines
keywords: Combinatorial chemistry; Kappa-opioid receptor; Molecular modeling; Tetrapeptide